For the year ending 2025-12-31, IEP had -$1,820M decrease in cash & cash equivalents over the period. -$654M in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -326 |
| Net loss from securities transactions | 323 |
| Purchases of securities | 1,372 |
| Proceeds from sales of securities | 1,990 |
| Payments to cover securities sold, not yet purchased | 773 |
| Proceeds from securities sold, not yet purchased | 612 |
| Changes in receivables and payables relating to securities transactions | 71 |
| Changes in derivative assets and liabilities | 146 |
| Loss (gain) on disposition of assets, net | 247 |
| Depreciation and amortization | 603 |
| Impairment | 40 |
| Deferred taxes | -9 |
| Other, net | 31 |
| Accounts receivable, net | -86 |
| Inventories | -28 |
| Other assets | 318 |
| Accounts payable | -135 |
| Accrued expenses and other liabilities | -1 |
| Net cash (used in) provided by operating activities | -313 |
| Capital expenditures | 341 |
| Turnaround expenditures | 197 |
| Proceeds from disposition of businesses and assets | 120 |
| Other, net | -16 |
| Net cash (used in) provided by investing activities | -402 |
| Investment segment distributions to non-controlling interests | -526 |
| Partnership contributions | 85 |
| Partnership distributions | 288 |
| Proceeds from sale of (purchase of) additional interests in consolidated subsidiaries | 72 |
| Dividends and distributions to non-controlling interests in subsidiaries | 77 |
| Proceeds from holding company senior notes | 495 |
| Repayments of holding company senior notes | 479 |
| Repurchase of senior notes held in treasury | 46 |
| Proceeds from subsidiary borrowings | 18 |
| Repayments of subsidiary borrowings | 189 |
| Other, net | -26 |
| Net cash used in financing activities | -1,105 |
| Net (decrease) increase in cash and cash equivalents and restricted cash and restricted cash equivalents | -1,820 |
| Cash and cash equivalents and restricted cash and restricted cash equivalents, beginning of period | 5,239 |
| Cash and cash equivalents and restricted cash and restricted cash equivalents, end of period | 3,419 |
ICAHN ENTERPRISES L.P. (IEP)
ICAHN ENTERPRISES L.P. (IEP)